These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Rare manifestations of the ovarian hyperstimulation syndrome: a report of two cases. Arikan G; Giuliani A; Gücer F; Auner H; Urdl W Clin Exp Obstet Gynecol; 1997; 24(3):154-6. PubMed ID: 9478304 [TBL] [Abstract][Full Text] [Related]
4. A case report of Ovarian hyperstimulation syndrome and corpus luteum rupture in twin pregnancies with IVF-ET. Luo Y; Shen H; Li H; Tan Z; Chen C; Chen W; He J Medicine (Baltimore); 2023 Jul; 102(27):e34238. PubMed ID: 37417637 [TBL] [Abstract][Full Text] [Related]
5. Experience with the bonanno catheter in the management of OHSS from IVF-ET Cycles. Okohue JE; Oriji VK; Ikimalo JI Niger J Clin Pract; 2017 Jul; 20(7):811-815. PubMed ID: 28791974 [TBL] [Abstract][Full Text] [Related]
6. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt. Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746 [TBL] [Abstract][Full Text] [Related]
8. Successful outcome of severe ovarian hyperstimulation syndrome (OHSS) with 27 liters of ascitic fluid removed by paracentesis. Grochowski D; Sola E; Kulikowski M; Kuczyński W; Wołczyński S; Szamatowicz M J Assist Reprod Genet; 1995 Jul; 12(6):394-6. PubMed ID: 8589562 [No Abstract] [Full Text] [Related]
9. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224 [TBL] [Abstract][Full Text] [Related]
10. Conversion of cycles involving ovarian hyperstimulation with intra-uterine insemination to in-vitro fertilization. Nisker J; Tummon I; Daniel S; Kaplan B; Yuzpe A Hum Reprod; 1994 Mar; 9(3):406-8. PubMed ID: 8006125 [TBL] [Abstract][Full Text] [Related]
11. Features of the Renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome. Delbaere A; Bergmann PJ; Englert Y J Assist Reprod Genet; 1997 May; 14(5):241-4. PubMed ID: 9147235 [TBL] [Abstract][Full Text] [Related]
12. Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. Tomazevic T; Meden-Vrtovec H J Assist Reprod Genet; 1996 Apr; 13(4):282-6. PubMed ID: 8777340 [TBL] [Abstract][Full Text] [Related]
13. Ovarian salvage in bilaterally complicated severe ovarian hyperstimulation syndrome. Al Omari W; Ghazal-Aswad S; Sidky IH; Al Bassam MK Fertil Steril; 2011 Aug; 96(2):e77-9. PubMed ID: 21718996 [TBL] [Abstract][Full Text] [Related]
14. Unsuspected adverse effect of albumin in severe ovarian hyperstimulation syndrome: a case report. Darii N; Pavlovic M; Doroftei B; Emil A JBRA Assist Reprod; 2019 Oct; 23(4):430-433. PubMed ID: 31058477 [TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of severe late-onset ovarian hyperstimulation syndrome and its impact on the live birth outcome of IVF-ET]. Ma XW; Yin JW; Yang R; Yang S; Li J; Wang Y; Li R Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):678-685. PubMed ID: 36177579 [No Abstract] [Full Text] [Related]
16. Modern management of ovarian hyperstimulation syndrome. Rizk B; Aboulghar M Hum Reprod; 1991 Sep; 6(8):1082-7. PubMed ID: 1806565 [TBL] [Abstract][Full Text] [Related]
17. Late ovarian hyperstimulation syndrome after controlled ovarian stimulation in a woman with systemic lupus erythematosus and lupus nephritis. Crochet JR; Yeh JS; Clowse ME; Copland SD Fertil Steril; 2011 Apr; 95(5):1786.e13-6. PubMed ID: 21168129 [TBL] [Abstract][Full Text] [Related]
18. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146 [TBL] [Abstract][Full Text] [Related]
19. Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy. Hatzipetros I; Gocze PM; Cziraky K; Kovacs K; Kalman E; Farkas B Reprod Biol Endocrinol; 2013 Sep; 11():91. PubMed ID: 24028152 [TBL] [Abstract][Full Text] [Related]
20. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Sher G; Zouves C; Feinman M; Maassarani G Hum Reprod; 1995 Dec; 10(12):3107-9. PubMed ID: 8822423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]